Cannabidiol-Loaded Nanocarriers and Their Therapeutic Applications

Pharmaceuticals (Basel). 2023 Mar 24;16(4):487. doi: 10.3390/ph16040487.


Cannabidiol (CBD), one of the most promising constituents isolated from Cannabis sativa, exhibits diverse pharmacological actions. However, the applications of CBD are restricted mainly due to its poor oral bioavailability. Therefore, researchers are focusing on the development of novel strategies for the effective delivery of CBD with improved oral bioavailability. In this context, researchers have designed nanocarriers to overcome limitations associated with CBD. The CBD-loaded nanocarriers assist in improving the therapeutic efficacy, targetability, and controlled biodistribution of CBD with negligible toxicity for treating various disease conditions. In this review, we have summarized and discussed various molecular targets, targeting mechanisms and types of nanocarrier-based delivery systems associated with CBD for the effective management of various disease conditions. This strategic information will help researchers in the establishment of novel nanotechnology interventions for targeting CBD.

Keywords: Cannabis sativa; bioavailability; cannabidiol; molecular mechanism; nanomedicine.

Publication types

  • Review

Grants and funding

This research received no external funding.